Skip to main content

Table 2 Drug purchase rates in Spain and Norway adjusted by age and sex, including both immigrants and natives. All main anatomical and 10 most used therapeutic ATC groups

From: Patterns of pharmaceutical use for immigrants to Spain and Norway: a comparative study of prescription databases in two European countries

ATC Drug Spain % (95 % CI) Norway % (95 % CI)
Main anatomical ATC groups
 A Alimentary tract and metabolism 27.9 (27.8–27.9) 12.9 (12.9–13)
 B Blood and blood forming organs 11.4 (11.4–11.5) 10.4 (10.4–10.5)
 C Cardiovascular system 22.1 (22.0–22.2) 18.0 (17.9–18)
 D Dermatologicals 15.6 (15.5–15.7) 12.1 (12.1–12.1)
 G Genito-urinary system and sex hormones 6.8 (6.7–6.8) 14.6 (14.6–14.6)
 H Systemic hormonal preparations, excluding sex hormones and insulins 8.3 (8.3–8.4) 7.2 (7.2–7.3)
 J Antiinfectives for systemic use 32.7 (32.5–32.8) 23.7 (23.7–23.8)
 L Antineoplastic and immunomodulating agents 1.1 (1.0–1.1) 1.4 (1.4–1.41)
 M Musculo-skeletal system 38 (37.9–38.1) 18.5 (18.5–18.6)
 N Nervous system 35.2 (35.14–35.4) 24.5 (24.4–24.5)
 P Antiparasitic products, insecticides and repellents 0.8 (0.8–0.9) 1.9 (1.8–1.9)
 R Respiratory system 33.9 (33.8–34) 23.7 (23.6–23.7)
 S Sensory organs 15.4 (15.3–15.4) 12.1 (12.1–12.2)
Main therapeutic ATC groups
 A02B Drugs for peptic ulcer and gastro-oesophageal reflux disease 18.5 (18.4–18.5) 5.9 (5.9–5.9)
 B01A Antithrombotic Agents 7.1 (7.1–7.1) 8.7 (8.7–8.7)
 C10A Lipid modifying agents 9.8 (9.7–9.8) 8.3 (8.3–8.3)
 J01C Beta-lactam antibacterials, penicillins 20.4 (20.3–20.6) 15.7 (15.7–15.8)
 J01F Macrolides, lincosamides and streptogramins 7.3 (7.3–7.4) 6.4 (6.4–6.5)
 M01A Antiinflammatory and antirheumatic products, non-steroids 34.3 (34.2–34.4) 17.1 (17–17.1)
 N02B Other analgesics and antipyretics 23.5 (23.4–23.6) 6.0 (6.0–6.0)
 N05B Anxiolytics 11.0 (11–11.1) 5.7 (5.7–5.8)
 N06A Antidepressants 7.0 (6.9–7.0) 5.9 (5.8–5.9)
 R06A Antihistamines for systemic use 11.2 (11.1–11.3) 10.7 (10.7–10.7)